Xanthus Pharmaceuticals
company
About
Xanthus is a biopharmaceutical company.
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $25M
- Industries
- Biopharma,Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 1, 2001
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Xanthus Pharmaceuticals Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, acquisition, and commercialization of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$55.80M
Xanthus Pharmaceuticals has raised a total of
$55.80M
in funding over 2 rounds. Their latest funding was raised on
Dec 1, 2006 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 1, 2006 | Series B | $25M | 1 | — | — | Detail |
| Dec 12, 2003 | Series B | $30.80M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Xanthus Pharmaceuticals is funded by 1 investors.
CDP Capital Technology Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
CDP Capital Technology Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
